Maisha Meds Inc

Balance Sheet
Fiscal Year: 2024
Jan 1, 2024 – Dec 31, 2024
Assets in 2024 (Year End)
$1,179,960
Cash & Equivalents
98%
Prepaid Expenses
1%
Property, Plant, & Equipment (net)
<1%
Receivables (Non-Related)
<1%
Investments
<1%
Related-Party Receivables
0%
Inventories
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$102,721
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$1,246,385
$1,157,068
-7%
Receivables (Non-Related)
-
$5,159
-
Related-Party Receivables
-
$0
-
Inventories
-
-
-
Prepaid Expenses
$8,553
$11,949
+40%
Investments
-
$51
-
Property, Plant, & Equipment (net)
$11,465
$5,733
-50%
Other Assets
$18,111
$0
-100%
Total Assets
$1,284,514
$1,179,960
-8%
Liabilities
2023
2024
Change
Payables & Accruals
$205,361
$102,721
-50%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
$0
-
Other Liabilities
$19,512
$0
-100%
Total Liabilities
$224,873
$102,721
-54%
Net assets
2023
2024
Change
Restricted Net Assets
$490,854
$499,006
+2%
Unrestricted Net Assets
$568,787
$578,233
+2%
Net assets
2023
2024
Change
Net assets
+$1,059,641
+$1,077,239
+2%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)